You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
金斯瑞生物科技(01548.HK)澄清称范晓虎对传奇及Janssen协议的里程碑付款陈述不准确
格隆汇 07-23 22:00

格隆汇7月23日丨金斯瑞生物科技(01548.HK)公布,于2017年12月22日,公司非全资附属传奇美国、传奇爱尔兰(统称“传奇”)及Janssen Biotech, Inc.就各方在诊断、预防及治疗多发性骨髓瘤领域的若干产品开发、制造及商业化方面的协作以及交叉许可授权订立协作及特许协议。

于2019年4月16日,公司附属公司传奇生物科技有限公司首席科学官范晓虎博士于国家转化医学研究中心(上海)、江宁区政府、江苏省人民医院及该公司组织的新闻发布会上作出发言。范博士在发言中对协议的里程碑付款作出若干不准确陈述。

为回应该等陈述,董事会谨此澄清,该等陈述属不准确。董事会谨此强调,范博士并无参与协议的商业及财务条款的谈判,也不知悉协议中所载后续里程碑付款的最终财务数据。范博士根据其个人意见及个人对预期里程碑付款金额的预期作出该等陈述,该等陈述不应被视为该公司未来盈利能力的任何指引。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account